Generics US generic drug major Mylan says that Matrix Laboratories, an Indian company in which it owns a controlling stake, has received tentative approval from the US Food and Drug Administration under the President‘s Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application for a fixed-dose combination of efavirenz, emtricitabine, tenofovir disoproxil fumarate tablets, 600mg/200mg/300 mg. This is the first and only generic version of this product and will be eligible for purchase outside the U.S. in many developing countries. 19 August 2009